Koios signs final agreement to acquire Retox Beverage Corp., The Canadian Business Journal

Denver and Vancouver, British Columbia, April 6, 2022 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (“Company” or “Koios”) In addition to the February 28, 2022 news release, we are pleased to announce that we have signed the final agreement dated April 5, 2022.agreement”) Acquire all issued and issued securities from shareholders of Retox Beverage Corp. (“”Retox”), A privately held beverage company focused on the production of creative soft drinks, sodas and selzers (“”)Get“).

In consideration of the acquisition, we will issue 15,000,000 units (“unit) Pay Retox shareholders a total consideration of $ 1,500,000 at a deemed value of $ 0.10 per unit. Each unit consists of one common stock (each unit is “share“) And one common stock purchase warrant (“respectively”warrantIt can be exercised to acquire one additional share at a price of $ 0.175 for 12 months from closing. The acquisition will be completed in accordance with the applicable securities law and the exemption from the available prospectus.

The acquisition is expected to close before April 30, 2022 and requires normal closing conditions and regulatory approval, including approval from the Canadian Stock Exchange, if applicable.

About Retox

Retox is a beverage company focused on the production of creative soft drinks, sodas and selzers, with a particular focus on formulating unique mixes of fruit and soda for the bar mix industry. Its product line includes fresher, healthier and lower sugar alternatives than current mixed products that are not readily available in the industry.

On behalf of our board of directors


“Chris Miller”

Chris Miller, CEO, Director

For more information, please contact:

Gina Barras

The Canadian Stock Exchange (CSE) has not been reviewed and is not responsible for the accuracy or validity of this release.

About Koios Beverage Corp.

We are an emerging functional beverage company with an available distribution network of over 4,400 retailers nationwide to sell our products. Koios has relationships with the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a unique blend of nootropics and natural organic compounds to increase human productivity without the use of harmful chemicals or irritants. Koios products have been shown to enhance concentration, concentration, mental abilities, memory retention, cognitive function, arousal, and brain abilities, producing mental clarity all day long. Its components are specially designed to target brain function by increasing blood flow, oxygen levels, and neural connections in the brain.

Koios manufactures one of the only beverages infused with MCT oil in the world. MCT oil is derived from coconut, which allows the body to burn fat more effectively, generate sustained energy from natural food sources, produce ketones in the brain, enhance brain function and clarity, and be healthy. It has been shown to support hormone production and help improve immunity. For more information, please visit our website.

Description of future prospects

This news release contains “forward-looking information” in the sense of applicable Canadian securities law. In many cases, but not always, information or information about the future outlook is “planning,” “expecting,” “not expecting,” “expected,” “estimating,” “intended,” or “predicting.” “Do”, “Unpredict”, “Believe”, or variations of such words or phrases, or certain actions, events, or outcomes are “possible”, “possible”, “possible” Taken, occurred, or achieved, stating “yes”, “possible”, “possible”. Information on the future outlook for this news release includes the overall performance of the functional beverage market, assumptions affected by significant risks and uncertainties, assumptions that all conditions up to the completion of the acquisition are met, and It contains a statement about the assumption that the acquisition will take place. Complete under the conditions stipulated in the contract. Forward-looking information reflects management’s current expectations based on currently available information, with many risks that may result in significantly different results from those described in the forward-looking information. Affected by uncertainty. We believe that the assumptions and factors used to create information about the future outlook are reasonable, but we should not place undue reliance on such information and such events have been disclosed. There is no guarantee that it will not occur within the time frame or at all. Factors that may cause actual results or events to differ materially from current expectations include: (Ii) Growth and size change of the functional beverage market. (Iii) Other factors beyond our control. We operate in a rapidly evolving environment. New risk factors occur from time to time and it is not possible for our management to predict all risk factors, and we have the impact of all factors on our business or any combination of factors or factors. It is also not possible to assess how much it affects. Actual results may differ from those contained in the forward-looking information. The forward-looking information contained in this news release was produced as of the date of this news release, and we will update or revise the forward-looking information as a result of new information, future events, etc. Explicitly deny an intention or obligation. , Except as required by applicable law.

The statements in this news release have not been evaluated by Health Canada or the US Food and Drug Administration. Due to individual differences, the benefits of taking our products vary from person to person. No claim or warranty can be made regarding the impact of our products on personal health and well-being. Our products are not intended to diagnose, treat, cure or prevent any disease.

This news release typically bears the trademark name (or brand name) of the third party entity with reference to (i) the relationship between Koios and the third party entity mentioned in this release and / or (ii). Each product) may be included. In this release, client / vendor / service provider stakeholders whose relationship with Koios is referenced. All rights to such trademarks are reserved by their respective owners or licensees.

CBJ News Maker

Koios signs final agreement to acquire Retox Beverage Corp., The Canadian Business Journal

Source link Koios signs final agreement to acquire Retox Beverage Corp., The Canadian Business Journal

Related Articles

Back to top button